Tobacco Cigarette

Phase 1

HHannah Harris

Tobacco Cigarette is one of 3 therapeutic programs targeting Cannabis Use. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Cannabis UseNot yet recruiting

Cannabis UsePhase 1

Not yet recruiting

Competition

Competitive Landscape

2 competitors in Cannabis Use

#DrugCompanyPhaseTrials

Mounjaro

Eli Lilly

Approved

1 2

Cannabis

TTO Pharmaceuticals

Phase 1

4 3

Tobacco Cigarette

HHannah Harris

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 1Not yet recruiting

Cannabis Use

NCT07694466

Clinical

Trials by Indication[1]

Cannabis Use1 trial

Lung Health and Breath Biomarkers: Acute Effects of Combusted and Vaporized Cannabis Inhalation Compared to Tobacco Cigarette Combustion in the Human Laboratory

Not yet recruiting·HHannah Harris·Phase 1·NCT07694466·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tobacco Cigarette. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Tobacco Cigarette. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Hannah Harris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: HHannah Harris

Tobacco Cigarette

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Cannabis Use1 trial

References

Drug Info

Quick Facts

Related News